Serendipitous Recanalization of Basilar Artery Occlusion

Conclusions: Tenecteplase has enhanced biochemical and pharmacokinetic properties that may be ideal for treatment of basilar artery occlusion and should be further investigated in a randomized clinical trial.

Source: Journal of Stroke and Cerebrovascular Diseases - July 8, 2013 Category: Neurology Authors: Jeffrey A. Switzer, Scott E. Forseen, Askiel Bruno, David C. Hess Tags: Case Reports Source Type: research